The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Find out which platform is best for retirement investing to enhance your portfolio. Make informed choices for your financial future.
24,828 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Global fertilizer prices surge as conflict with Iran disrupts shipments, tightening U.S. inputs for farmers prepping ...
Rising political rhetoric around offshore wind threatens U.S. infrastructure spending, risking delays and higher cost...
A luxury tax on second homes could reshape New York City's budget and housing market. This article weighs the potenti...
Kratos stock dropped again today as investors weigh a costly valuation against uneven earnings and shifting defense b...
As AI deployment accelerates, investors are racing into energy stocks, naming a cluster of seven top names the munifi...
U.S. short-term yields spike again, pushing traders toward the SGOV ETF for cash-like income with minimal duration ri...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
The European Union plans to fund its next long-term budget, but real change goes beyond adding taxes. This article ex...
A Las Vegas real estate agent says social media became 100% of his client pipeline after one educational video went v...
Bitcoin is in a slow bleed phase as distribution-driven selling deepens, with May’s rally fading and spot ETF flows t...
A late May security review uncovered an AI assisted Zcash flaw in the Orchard pool that could have created counterfei...